News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Lawsuits Aim to Kill Onyx Pharmaceuticals, Inc. (ONXX)-Amgen (AMGN) Deal


9/9/2013 8:39:31 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

At least six purported class-action lawsuits have been filed against Onyx Pharmaceuticals Inc., claiming that the company's board of directors conducted an allegedly unfair process in lining up a $10.4 billion deal to be acquired by Amgen Inc. The lawsuits, Onyx said in a Securities and Exchange Commission filing Friday, were filed between Aug. 28 and Sept. 4, and one already has been dismissed at the request of the plaintiff. One of the suits was filed by the Louisiana Municipal Policy Employees' Retirement System.

Help employers find you! Check out all the jobs and post your resume.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES